STOCK RESEARCH & ANALYSIS
| Q-o-Q | REVENUES | OPERATING PROFIT | PROFIT AFTER TAX | EPS | Updated : 29-Oct-21 | Details👇 |
| Consolidated | Sep2021 Audited |
Jun2021 Audited |
Mar2021 UnAudited |
Dec2020 UnAudited |
Sep2020 Audited |
Jun2020 Audited |
Mar2020 UnAudited |
Dec2019 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹5,787 Cr | ₹4,945 Cr | ₹4,768 Cr | ₹4,942 Cr | ₹4,911 Cr | ₹4,427 Cr | ₹4,449 Cr | ₹4,397 Cr |
| Expenses | ₹4,427 Cr | ₹4,211 Cr | ₹3,715 Cr | ₹4,403 Cr | ₹3,755 Cr | ₹3,305 Cr | ₹3,500 Cr | ₹4,686 Cr |
| Operating Income | ₹1,360 Cr | ₹735 Cr | ₹1,053 Cr | ₹539 Cr | ₹1,156 Cr | ₹1,121 Cr | ₹949 Cr | ₹-289 Cr |
| Other Income | ₹206 Cr | ₹108 Cr | ₹83 Cr | ₹71 Cr | ₹51 Cr | ₹87 Cr | ₹74 Cr | ₹67 Cr |
| Interest | ₹23 Cr | ₹19 Cr | ₹30 Cr | ₹19 Cr | ₹25 Cr | ₹23 Cr | ₹23 Cr | ₹15 Cr |
| Depreciation | ₹294 Cr | ₹284 Cr | ₹309 Cr | ₹311 Cr | ₹317 Cr | ₹292 Cr | ₹274 Cr | ₹287 Cr |
| Profit Before Tax | ₹1,248 Cr | ₹539 Cr | ₹797 Cr | ₹280 Cr | ₹866 Cr | ₹893 Cr | ₹726 Cr | ₹-524 Cr |
| Profit After Tax | ₹971 Cr | ₹364 Cr | ₹539 Cr | ₹13 Cr | ₹765 Cr | ₹587 Cr | ₹771 Cr | ₹-556 Cr |
| EPS | ₹59.84 | ₹22.86 | ₹33.49 | ₹1.68 | ₹46.44 | ₹35.78 | ₹47.00 | ₹-32.39 |
| Peers & Returns | 1W | 1M | 1Y |
| DR REDDYS LABORATORIES | -2.4% | -4.1% | -6.2% |
| SUN PHARMACEUTICAL INDUSTRIES | -1.1% | -5.3% | 36.4% |
| DIVIS LABORATORIES | -5.6% | -10.5% | 28.2% |
| CIPLA | -2.6% | -1.7% | 17.3% |
| GLAND PHARMA | -3.1% | -3.4% | 62.5% |
| PIRAMAL ENTERPRISES | 4.5% | -4.9% | 81.4% |
| CADILA HEALTHCARE | 0.4% | -6.6% | -0.4% |
| TORRENT PHARMACEUTICALS | 5.5% | 8.2% | 14.4% |
| ALKEM LABORATORIES | -0.6% | -4.2% | 22.7% |
| Revenues | |
|---|---|
| Q-o-Q | 17.02 % |
| Y-o-Y | 17.84 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Sep2021 | ₹5,787 Cr | 17.02 | |
| Jun2021 | ₹4,945 Cr | 3.71 | |
| Mar2021 | ₹4,768 Cr | -3.51 | |
| Dec2020 | ₹4,942 Cr | 0.63 | |
| Sep2020 | ₹4,911 Cr | 10.94 | |
| Jun2020 | ₹4,427 Cr | -0.50 | |
| Mar2020 | ₹4,449 Cr | 1.18 | |
| Dec2019 | ₹4,397 Cr | - | |
| Operating Profit | |
|---|---|
| Q-o-Q | 85.13 % |
| Y-o-Y | 17.62 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Sep2021 | ₹1,360 Cr | 85.13 | |
| Jun2021 | ₹735 Cr | -30.26 | |
| Mar2021 | ₹1,053 Cr | 95.29 | |
| Dec2020 | ₹539 Cr | -53.35 | |
| Sep2020 | ₹1,156 Cr | 3.10 | |
| Jun2020 | ₹1,121 Cr | 18.13 | |
| Mar2020 | ₹949 Cr | Positive | |
| Dec2019 | ₹-289 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 58.25 % |
| Y-o-Y | -0.17 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Sep2021 | 23.5% | 58.25 | |
| Jun2021 | 14.85% | -32.78 | |
| Mar2021 | 22.09% | 102.47 | |
| Dec2020 | 10.91% | -53.65 | |
| Sep2020 | 23.54% | -7.07 | |
| Jun2020 | 25.33% | 18.70 | |
| Mar2020 | 21.34% | Positive | |
| Dec2019 | -6.57% | - | |
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 166.93 % |
| Y-o-Y | 27.02 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Sep2021 | ₹971 Cr | 166.93 | |
| Jun2021 | ₹364 Cr | -32.55 | |
| Mar2021 | ₹539 Cr | 4,114.06 | |
| Dec2020 | ₹13 Cr | -98.33 | |
| Sep2020 | ₹765 Cr | 30.26 | |
| Jun2020 | ₹587 Cr | -23.84 | |
| Mar2020 | ₹771 Cr | Positive | |
| Dec2019 | ₹-556 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 127.99 % |
| Y-o-Y | 7.77 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Sep2021 | 16.78 % | 127.99 | |
| Jun2021 | 7.36 % | -34.92 | |
| Mar2021 | 11.31 % | 4,250.00 | |
| Dec2020 | 0.26 % | -98.33 | |
| Sep2020 | 15.57 % | 17.42 | |
| Jun2020 | 13.26 % | -23.44 | |
| Mar2020 | 17.32 % | Positive | |
| Dec2019 | -12.64 % | - | |
| EPS | |
|---|---|
| Q-o-Q | 161.77 % |
| Y-o-Y | 28.85 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Sep2021 | ₹59.84 | 161.77 | |
| Jun2021 | ₹22.86 | -31.74 | |
| Mar2021 | ₹33.49 | 1,893.45 | |
| Dec2020 | ₹1.68 | -96.38 | |
| Sep2020 | ₹46.44 | 29.79 | |
| Jun2020 | ₹35.78 | -23.87 | |
| Mar2020 | ₹47 | Positive | |
| Dec2019 | ₹-32.39 | - | |
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE GREENEX | 0.8% | -3.7% | 40.1% |
| S&P BSE ALLCAP | 0.7% | -2.8% | 38.3% |
| S&P BSE 500 | 0.6% | -3% | 37.1% |
| S&P BSE LARGE MIDCAP | 0.6% | -3.1% | 34.2% |
| S&P BSE 200 | 0.6% | -3.1% | 34.8% |
| S&P BSE 250 LARGEMIDCAP | 0.5% | -3.1% | 35.5% |
| S&P BSE CARBONEX | 0.5% | -3.1% | 32.2% |
| S&P BSE 100 | 0.5% | -3.1% | 32.6% |
| S&P BSE 100 ESG INDEX | 0.4% | -3.3% | 33.5% |
| S&P BSE LARGECAP | 0.4% | -3.1% | 32.1% |
| S&P BSE 100 LARGECAP TMC | 0.4% | -3.1% | 32.5% |
| MFG | 0.4% | -4.4% | 30.8% |
| S&P BSE SENSEX50 | 0.4% | -3.3% | 31.3% |
| S&P BSE SENSEX | 0.3% | -3.1% | 29.1% |
| S&P BSE 500 SHARIAH | -0.2% | -1.9% | 39.1% |
| S&P BSE DIVIDEND STABILITY | -0.2% | -7.3% | 32.6% |
| S&P BSE HEALTHCARE | -1.2% | -0.5% | 20.1% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY500 MULTICAP 50:25:25 | 1% | -2.4% | NA |
| NIFTY LARGE MIDCAP 250 | 0.8% | -2.8% | 41.7% |
| NIFTY 100 EQUAL WEIGHT | 0.8% | -3.7% | 39.2% |
| NIFTY 500 | 0.7% | -2.9% | 36.9% |
| NIFTY 200 | 0.6% | -3.1% | 34.4% |
| NIFTY 100 | 0.4% | -3.1% | 32.1% |
| NIFTY 50 | 0.4% | -3.3% | 31% |
| NIFTY50 EQUAL WEIGHT | 0.4% | -4.3% | 39.4% |
| NIFTY ALPHA QTY VAL LOW-VOL 30 | 0.2% | -3.8% | 26.1% |
| NIFTY ALPHA LOW-VOLATILTY 30 | 0.1% | -2.6% | 30.9% |
| NIFTY ALPHA QTY LOW-VOLAT.30 | -0.4% | -3.4% | 27.4% |
| NIFTY100 LOW VOLATILITY 30 | -0.7% | -4% | 25.9% |
| NIFTY PHARMA | -0.9% | -3% | 9.9% |
| NIFTY GROWTH SECTOR 15 | -1.3% | -4.3% | 13.2% |
| NIFTY HEALTHCARE | -1.4% | -0.6% | NA |
#15A, 4th Floor, City Vista, Tower A,
Suite No.984, Fountain Road,
Kharadi, Pune - 411014
Contact Us
support@smart-investing.in
Smart-Investing.in
Pricing
Video Course
Blog
Tools
Screener
Compare
Analyze Portfolio
© 2019 - 2021 Smart-Investing.in. All rights reserved. Built with ❤️ in India
Disclaimer
The information on this site is for educational purposes only and is not investment/trading advice/research and may be delayed.
We don't make any Buy/Sell recommendations and don't give any price targets.
This tool provides statistical summaries of financial data in easy to understand visual form for informational purpose only.
Please do your own research before making any investment decisions.
Equity investments are volatile and high risk in nature. Don't invest more than what you can afford to lose. Past Performance is not indicative of future returns.
We have affiliate relationships with Amazon and Zerodha.
Financial Data Source: Accord Fintech |
Methodology |
Privacy Policy |
Terms & Conditions |
SEBI Registered Research Analyst Registration No : INH000007377 |
Disclosure